Inactivated cowpea mosaic virus for in situ vaccination: differential efficacy of formalin vs UV-inactivated formulations

E Jung, C Mao, M Bhatia, EC Koellhoffer… - Molecular …, 2022 - ACS Publications
Cowpea mosaic virus (CPMV) has been developed as a promising nanoplatform technology
for cancer immunotherapy; when applied as in situ vaccine, CPMV exhibits potent, systemic …
被引用次数：7 相关文章

Inactivated Cowpea Mosaic Virus for In Situ Vaccination: Differential Efficacy of Formalin vs UV-Inactivated Formulations

E Jung, C Mao, M Bhatia… - Molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
Cowpea mosaic virus (CPMV) has been developed as a promising nanoplatform technology
for cancer immunotherapy; when applied as in situ vaccine, CPMV exhibits potent, systemic …

Inactivated Cowpea Mosaic Virus for In Situ Vaccination: Differential Efficacy of Formalin vs UV-Inactivated Formulations.

E Jung, C Mao, M Bhatia, EC Koellhoffer… - Molecular …, 2022 - europepmc.org
Cowpea mosaic virus (CPMV) has been developed as a promising nanoplatform technology
for cancer immunotherapy; when applied as in situ vaccine, CPMV exhibits potent, systemic …
[HTML] nih.gov

[HTML][HTML] Inactivated Cowpea Mosaic Virus for In Situ Vaccination: Differential Efficacy of Formalin vs UV-Inactivated Formulations

E Jung, C Mao, M Bhatia, EC Koellhoffer… - Molecular …, 2023 - ncbi.nlm.nih.gov
Cowpea mosaic virus (CPMV) has been developed as a promising nanoplatform technology
for cancer immunotherapy; when applied as in situ vaccine, CPMV exhibits potent, systemic …

Inactivated Cowpea Mosaic Virus for In Situ Vaccination: Differential Efficacy of Formalin vs UV-Inactivated Formulations.

E Jung, C Mao, M Bhatia, EC Koellhoffer… - Molecular …, 2022 - europepmc.org
Cowpea mosaic virus (CPMV) has been developed as a promising nanoplatform technology
for cancer immunotherapy; when applied as in situ vaccine, CPMV exhibits potent, systemic …